Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > After today🤞
View:
Post by Duster340 on Jan 12, 2024 11:22am

After today🤞

only 3 more full trading days before the 18th. pretty sure the stock will be moving higher before the start of the conversation. maybe we get some big players, institunial buying during and after the information drop. fingers crossed for a buying frenzy.
Comment by Harper75 on Jan 12, 2024 12:56pm
IMO we are a ways off from any Ititutional buying...
Comment by MrMugsy on Jan 12, 2024 8:31pm
True - agreed !!! These are retail investors ... and I'd bet many are just coming back now (past owners of ATE). Important institutional buying will be closely related to a US market move.  IMO.
Comment by Jefnan1 on Jan 13, 2024 5:55pm
This company is too small for any  institution to have any interest unless they decide to buy the whole thing
Comment by MrMugsy on Jan 14, 2024 10:34am
It is not in the right time for Institutional investors - but  - that could change quickly as risk is reduced and success is had.  Also, it isn't the institutional investors who would buy it - honor would go to the Pharma companies.
Comment by MrMugsy on Jan 12, 2024 8:34pm
If anything - January 18th is about the power of OTENA. Some may be obvious - the rest will require some "reading between the lines." As always.